Use of sodium-glucose cotransporter type 2 inhibitors (iSGLT2) in heart failure(HF).
Abstract
Aunque inicialmente los iSGLT2 fueron aprobados para el tratamiento de la hiperglucemia en pacientes con Diabetes Mellitus tipo 2 (DM2), se comprobaron, a través de numerosos estudios sus efectos beneficiosos cardiovasculares en pacientes con y sin DM2.
##submission.downloads##
Published
2023-12-30
##submission.howToCite##
1.
Rodríguez Álvarez R, Gutierrez Álvarez M, Varela-Portas Alvarez P. Use of sodium-glucose cotransporter type 2 inhibitors (iSGLT2) in heart failure(HF). Cad.Aten.Primaria [Internet]. 2023 Dec. 30 [cited 2024 May 17];29(1). Available from: https://journal.agamfec.com/index.php/cadernos/article/view/326
Issue
Section
Scientific Editorial
##submission.license##
##submission.copyrightStatement##
##submission.license.cc.by-nc-nd4.footer##This journal is publish under a license
CC Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)